DoW Reconstructive Transplant, Concept Award

The Defense Health Agency Contracting Activity is soliciting applications for the fiscal year 2026 Reconstructive Transplant Research Program Concept Award under solicitation HT942526RTRPCA. This program supports the exploration of highly innovative new concepts or untested theories that address critical problems in reconstructive transplantation, specifically those aligned with FY26 RTRP Focus Areas. The award is designed for high-risk, high-reward research that introduces new paradigms or creative perspectives, and it explicitly excludes clinical trials and incremental advances based on existing data. Early-career investigators at or above the postdoctoral fellow level are encouraged to apply. Funding is capped at 200,000 dollars per award for a maximum period of performance of 18 months, with an overall program appropriation of 12 million dollars. The selection process involves a two-tier review consisting of a peer review for technical merit followed by a programmatic review for relevance to military health and program priorities. Applicants must maintain active registrations in SAM.gov, eBRAP.org, and Grants.gov. Key submission requirements include a three-page Statement of Work, a one-page Innovation Statement, and a one-page Post-Award Transition Plan. All applications must be submitted by the specified deadlines, with full applications from extramural organizations required to go through the Grants.gov Workspace. Special attention is required for the disclosure of foreign affiliations of key personnel and the approval of the DHA R&D Office of Research and Regulatory Compliance for any research involving human or animal subjects.